- Brazil
- /
- Healthcare Services
- /
- BOVESPA:QUAL3
Pinning Down Qualicorp Consultoria e Corretora de Seguros S.A.'s (BVMF:QUAL3) P/S Is Difficult Right Now
There wouldn't be many who think Qualicorp Consultoria e Corretora de Seguros S.A.'s (BVMF:QUAL3) price-to-sales (or "P/S") ratio of 0.4x is worth a mention when the median P/S for the Healthcare industry in Brazil is similar at about 0.6x. Although, it's not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.
Our free stock report includes 3 warning signs investors should be aware of before investing in Qualicorp Consultoria e Corretora de Seguros. Read for free now.See our latest analysis for Qualicorp Consultoria e Corretora de Seguros
What Does Qualicorp Consultoria e Corretora de Seguros' Recent Performance Look Like?
While the industry has experienced revenue growth lately, Qualicorp Consultoria e Corretora de Seguros' revenue has gone into reverse gear, which is not great. Perhaps the market is expecting its poor revenue performance to improve, keeping the P/S from dropping. However, if this isn't the case, investors might get caught out paying too much for the stock.
Keen to find out how analysts think Qualicorp Consultoria e Corretora de Seguros' future stacks up against the industry? In that case, our free report is a great place to start.What Are Revenue Growth Metrics Telling Us About The P/S?
There's an inherent assumption that a company should be matching the industry for P/S ratios like Qualicorp Consultoria e Corretora de Seguros' to be considered reasonable.
In reviewing the last year of financials, we were disheartened to see the company's revenues fell to the tune of 9.7%. The last three years don't look nice either as the company has shrunk revenue by 25% in aggregate. Accordingly, shareholders would have felt downbeat about the medium-term rates of revenue growth.
Looking ahead now, revenue is anticipated to slump, contracting by 1.5% each year during the coming three years according to the six analysts following the company. That's not great when the rest of the industry is expected to grow by 11% per annum.
In light of this, it's somewhat alarming that Qualicorp Consultoria e Corretora de Seguros' P/S sits in line with the majority of other companies. Apparently many investors in the company reject the analyst cohort's pessimism and aren't willing to let go of their stock right now. Only the boldest would assume these prices are sustainable as these declining revenues are likely to weigh on the share price eventually.
What We Can Learn From Qualicorp Consultoria e Corretora de Seguros' P/S?
Typically, we'd caution against reading too much into price-to-sales ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.
It appears that Qualicorp Consultoria e Corretora de Seguros currently trades on a higher than expected P/S for a company whose revenues are forecast to decline. With this in mind, we don't feel the current P/S is justified as declining revenues are unlikely to support a more positive sentiment for long. If the declining revenues were to materialize in the form of a declining share price, shareholders will be feeling the pinch.
And what about other risks? Every company has them, and we've spotted 3 warning signs for Qualicorp Consultoria e Corretora de Seguros (of which 1 is a bit concerning!) you should know about.
If these risks are making you reconsider your opinion on Qualicorp Consultoria e Corretora de Seguros, explore our interactive list of high quality stocks to get an idea of what else is out there.
Valuation is complex, but we're here to simplify it.
Discover if Qualicorp Consultoria e Corretora de Seguros might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BOVESPA:QUAL3
Qualicorp Consultoria e Corretora de Seguros
Qualicorp Consultoria e Corretora de Seguros S.A.
Moderate growth potential with mediocre balance sheet.
Market Insights
Community Narratives

